SBIR Phase II: Non-Invasive Intracranial Pressure Monitor

Information

  • NSF Award
  • 1330652
Owner
  • Award Id
    1330652
  • Award Effective Date
    8/1/2013 - 12 years ago
  • Award Expiration Date
    1/31/2017 - 8 years ago
  • Award Amount
    $ 635,000.00
  • Award Instrument
    Standard Grant

SBIR Phase II: Non-Invasive Intracranial Pressure Monitor

This Small Business Innovation Research (SBIR) Phase II project proposes to develop a noninvasive intracranial pressure (ICP) monitor based on a pilot clinical study correlating ocular blood pressure and blood flow parameters to ICP. The proposed novel device will combine several standard medical techniques used by ophthalmologists to gather data. The ultimate goal for this project is to develop a portable, easy-to-use unit that will be used by medical personnel on patients in the hospital, and prior to their arrival.<br/><br/>The broader impact/commercial potential of this project, if successful, will be to improve the diagnosis of patients with head injury by improving the diagnosis of elevated ICP, and reducing the complications associated with unnecessary invasive procedures. ICP monitoring is a common tool for physicians treating patients with acute intracranial hypertension caused by neurological disorders, trauma, and stroke. Knowledge of a patient's ICP progression aids the physician in determining the optimal medical and/or surgical treatment. Every year, these surgical procedures expose patients to significant complications. Commercialization of a noninvasive ICP monitor would significantly decrease the burden on patients and to the healthcare system in the diagnosis and treatment of head injury by determining ICP more cheaply and safely than current technologies. A non-invasive method also would address the need for additional long-term ICP monitoring data, and expand the knowledge of how mild or moderate traumatic brain injury relates to ICP.

  • Program Officer
    Ruth M. Shuman
  • Min Amd Letter Date
    7/29/2013 - 12 years ago
  • Max Amd Letter Date
    2/1/2016 - 9 years ago
  • ARRA Amount

Institutions

  • Name
    Third Eye Diagnostics, Inc.
  • City
    Bethlehem
  • State
    PA
  • Country
    United States
  • Address
    116 Research Drive
  • Postal Code
    180154731
  • Phone Number
    6506784101

Investigators

  • First Name
    Anthony
  • Last Name
    Bellezza
  • Email Address
    abellezza@3-e-d.com
  • Start Date
    7/29/2013 12:00:00 AM

Program Element

  • Text
    SMALL BUSINESS PHASE II
  • Code
    5373

Program Reference

  • Text
    SMALL BUSINESS PHASE II
  • Code
    5373
  • Text
    Biotechnology
  • Code
    8038
  • Text
    SBIR/STTR CAP
  • Code
    8240
  • Text
    SBIR Phase IIB